Atonic seizures in children: a meta-analysis comparing corpus callosotomy to vagus nerve stimulation

2020 ◽  
Vol 37 (1) ◽  
pp. 259-267 ◽  
Author(s):  
Vincent C. Ye ◽  
Alireza Mansouri ◽  
Nebras M. Warsi ◽  
George M. Ibrahim
Seizure ◽  
2013 ◽  
Vol 22 (1) ◽  
pp. 3-8 ◽  
Author(s):  
Guido Lancman ◽  
Michael Virk ◽  
Huibo Shao ◽  
Madhu Mazumdar ◽  
Jeffrey P. Greenfield ◽  
...  

2015 ◽  
Vol 51 ◽  
pp. 13-17 ◽  
Author(s):  
John D. Rolston ◽  
Dario J. Englot ◽  
Doris D. Wang ◽  
Paul A. Garcia ◽  
Edward F. Chang

Author(s):  
Vinzent Wolf ◽  
Anne Kühnel ◽  
Vanessa Teckentrup ◽  
Julian Koenig ◽  
Nils B. Kroemer

AbstractNon-invasive brain stimulation techniques, such as transcutaneous auricular vagus nerve stimulation (taVNS), have considerable potential for clinical use. Beneficial effects of taVNS have been demonstrated on symptoms in patients with mental or neurological disorders as well as transdiagnostic dimensions, including mood and motivation. However, since taVNS research is still an emerging field, the underlying neurophysiological processes are not yet fully understood, and the replicability of findings on biomarkers of taVNS effects has been questioned. Here, we perform a living Bayesian random effects meta-analysis to synthesize the current evidence concerning the effects of taVNS on heart rate variability (HRV), a candidate biomarker that has, so far, received most attention in the field. To keep the synthesis of evidence transparent and up to date as new studies are being published, we developed a Shiny web app that regularly incorporates new results and enables users to modify study selection criteria to evaluate the robustness of the inference across potential confounds. Our analysis focuses on 17 single-blind studies comparing taVNS versus sham in healthy participants. These newly synthesized results provide strong evidence for the null hypothesis (g = 0.011, CIshortest = [−0.103, 0.125], BF01 = 25.587), indicating that acute taVNS does not alter HRV compared to sham. To conclude, based on a synthesis of the available evidence to date, there is no support for the hypothesis that HRV is a robust biomarker for acute taVNS. By increasing transparency and timeliness, we believe that the concept of living meta-analyses can lead to transformational benefits in emerging fields such as non-invasive brain stimulation.


2020 ◽  
Vol 23 (6) ◽  
pp. 721-731 ◽  
Author(s):  
Yin‐Hsuan Lai ◽  
Yu‐Chen Huang ◽  
Liang‐Ti Huang ◽  
Ruei‐Ming Chen ◽  
Chiehfeng Chen

2002 ◽  
Vol 17 (2_suppl) ◽  
pp. 2S9-2S22 ◽  
Author(s):  
Edwin Trevathan

Infantile spasms and Lennox-Gastaut syndrome are rare but are important to child neurologists because of the intractable nature of the seizures and the serious neurologic comorbidities. New antiepileptic drugs offer more alternatives for treating both infantile spasms and Lennox-Gastaut syndrome. Selected children with infantile spasms are candidates for epilepsy surgery. Vagus nerve stimulation, corpus callosotomy, and the ketogenic diet are all options for selected children with Lennox-Gastaut syndrome. The epidemiology, clinical manifestations of the seizures, electroencephalographic characteristics, prognosis, and treatment options are reviewed for infantile spasms and Lennox-Gastaut syndrome. Additional therapies are needed for both infantile spasms and Lennox-Gastaut syndrome as many children fail to achieve adequate seizure control in spite of newer treatments. (J Child Neurol 2002;17:2S9—2S22).


CNS Spectrums ◽  
2001 ◽  
Vol 6 (9) ◽  
pp. 766-770 ◽  
Author(s):  
Steven Karceski

ABSTRACTLennox-Gastaut syndrome (LGS) is a severe form of childhood epilepsy that is usually refractory to medical management. When medications fail, alternative therapies are considered. Among these are two surgical options: corpus callosotomy and vagus nerve stimulation (VNS). Safety and efficacy are two important factors to consider when selecting an appropriate treatment. VNS is safer than callosotomy, but its efficacy is more difficult to assess. Available studies evaluate its effectiveness using a mixed population of patients (some with prior epilepsy surgery), a multitude of VNS settings, and variable endpoints. To estimate the efficacy of VNS in patients with LGS, a review of the medical literature and the VNS Patient Registry was performed. Within the limits of this type of study, the results showed that VNS appears equally as effective as callosotomy. Because VNS has a lower potential for adverse events, these results suggest that VNS should be considered first in appropriately selected patient.


2016 ◽  
Vol 5 ◽  
pp. 27-30 ◽  
Author(s):  
Davide Nasi ◽  
Maurizio Iacoangeli ◽  
Lucia Di Somma ◽  
Mauro Dobran ◽  
Alessandro Di Rienzo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document